- Home
- RXRX vs DGII Comparison
RXRX vs DGII Comparison
Compare RXRX & DGII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RXRX | DGII |
|---|---|---|
| Founded | 2013 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.0B |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | RXRX | DGII |
|---|---|---|
| Price | $3.50 | $56.26 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $7.50 | ★ $48.80 |
| AVG Volume (30 Days) | ★ 10.4M | 248.7K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 14.79 | ★ 77.05 |
| EPS | N/A | ★ 0.31 |
| Revenue | $74,681,000.00 | ★ $430,221,000.00 |
| Revenue This Year | $12.11 | $18.71 |
| Revenue Next Year | $82.52 | $7.22 |
| P/E Ratio | ★ N/A | $180.48 |
| Revenue Growth | ★ 26.92 | 1.46 |
| 52 Week Low | $2.80 | $26.69 |
| 52 Week High | $7.18 | $56.50 |
Technical Indicators
Market Signals| Indicator | RXRX | DGII |
|---|---|---|
| Relative Strength Index (RSI) | 51.04 | 67.90 |
| Support Level | $2.89 | $47.00 |
| Resistance Level | $3.99 | N/A |
| Average True Range (ATR) | 0.17 | 1.73 |
| MACD | 0.04 | 0.24 |
| Stochastic Oscillator | 52.41 | 90.39 |
Price Performance
Historical ComparisonAbout RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
About DGII Digi International Inc.
Digi International Inc is a Minnesota corporation that provides business and mission-critical Internet of Things (IoT) connectivity products and services. It operates through two segments: IoT Products & Services, which supports OEMs, enterprise, and government customers in deploying secure IoT connectivity solutions, and IoT Solutions, consisting of SmartSense and its Managed Network-as-a-Service (MNaaS) business offering wireless temperature and condition-based monitoring, employee task management, label printing, and other services. The company generates the majority of its revenue from the IoT Products & Services segment and mainly from the United States, with a presence in Europe, the Middle East and Africa, and the Rest of the world.